Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition causes ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

As cases of chronic kidney disease emerge in outdoor laborers around the world, scientists are finding that repeated damage ...

A new genetic study on the causes of chronic kidney disease that combined multiple health measurements has led to a more ...

She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) ...

Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease ...

Management of older adults with type 2 diabetes and chronic kidney disease is complex. These individuals often have multiple comorbidities, take several medications, and are at increased risk of ...

In contrast, when using the traditional race-adjusted creatinine-based equation (eGFRcr-ASR), the HR was 2.8 (95% CI, 1.6–4.9 ...

Bloating, abdominal pain, constipation? You might have diverticular disease — a condition that affects nearly 7 in 10 people ...

Researchers examined which participants developed kidney disease severe enough to require a dialysis known as continuous renal replacement therapy.

COVID-19 patients who are vaccinated -- and were hospitalized with reduced kidney function -- had better outcomes than unvaccinated patients, a new study finds.

Panelists discuss how economic considerations in immunoglobulin A (IgA) nephropathy medication management vary dramatically across chronic kidney disease (CKD) stages, with early intervention costs ...